Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Open accessAbstract
Background & aims Iron overload may be carcinogenic. Patients with hereditary hemochromatosis (HH) are reportedly at a 20-200-fold risk of intrahepatic cancer, but the reported risks for nonhepatobiliary cancers are conflicting. The risk of cancer in heterozygous individuals (estimated allele frequency, 1/10 to 1/20) is unknown. This study aimed to better assess these risks. Methods We performed a population-based cohort study of 1847 Swedish patients with HH and 5973 of their first-degree relatives using nationwide, population-based health and census registers. We used standardized incidence ratios (SIRs) as relative risk. Results With 62 liver cancers and 128 nonhepatobiliary cancers, patients with HH were at a 20-fold risk of liver cancer (SIR, 21; 95% confidence interval [CI], 16-22) but an almost unaltered risk of all other cancers (SIR, 1.2; 95% CI, 1.0-1.4), including nonelevated risks for several gastrointestinal tract cancers. At 10 years of follow-up, the absolute risk of liver cancer was 6% among men and 1.5% among women. With 21 liver cancers and 508 nonhepatobiliary cancers, first-degree relatives were at an unaltered risk of extrahepatic cancer (SIR, 1.0; 95% CI, 0.9-1.1, including unelevated risks for gastrointestinal cancers) but at a modest and historic increased risk of hepatobiliary cancer (SIR, 1.5; 95% CI, 1.0-2.4), the histopathologic spectrum of which differed from the patients. Conclusions Patients (particularly men) with HH are at increased risk for hepatocellular cancer, although the magnitude of the risk is lower than previous estimates. Overall cancer risk in first-degree relatives does not seem to be increased.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Murine erythroleukemia cells that overexpress ferritin H displayed lower levels of the labile iron pool and ROS.
“Murine erythroleukemia cells that overexpress ferritin H displayed lower levels of the labile iron pool and ROS (78).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
Ferritin acts as an antioxidant protein.
“Accumulating evidence shows that ferritin acts as an antioxidant protein (59, 60, 78, 159, 227, 243).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
Induction of ferritin mRNA was observed in mouse liver and erythroid cells treated with oxidative stress-inducing compounds.
“induction of ferritin mRNA was observed in mouse liver (303) and erythroid cells (78) treated with oxidative stress–inducing compounds.”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
Overexpression or knockdown of ferritin expression in mammalian cells has proven the cytoprotective role of ferritin under prooxidative conditions.
“overexpression or knockdown of ferritin expression in mammalian cells has proven the cytoprotective role of ferritin under prooxidative conditions (59, 60, 78, 159, 227, 243).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,063 · see citing works
Long-term survival in patients with hereditary hemochromatosis
Niederau, C., Fischer, R., Pürschel, A., Stremmel, W., Häussinger, D., & Strohmeyer, G. W. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613000 · Cited by 885 · see citing works
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823 · see citing works
Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors
Edwards, C. Q., Griffen, L. M., Goldgar, D. E., Drummond, C., Skolnick, M. H., & Kushner, J. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182103 · Cited by 628 · see citing works
Body Iron Stores and the Risk of Cancer
Stevens, R. G., Jones, D. Y., Micozzi, M. S., & Taylor, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191603 · Cited by 576 · see citing works
Mattsson, B., & Wallgren, A. (1984) · Acta Radiologica Oncology · doi:10.3109/02841868409136026 · Cited by 563 · see citing works
Iron-induced carcinogenesis: The role of redox regulation
Toyokuni, S. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02111-6 · Cited by 562 · see citing works
HFE Gene and Hereditary Hemochromatosis: A HuGE Review
Hanson, E. H. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.3.193 · Cited by 432 · see citing works
Jazwinska, E. C., Cullen, L. M., Busfield, F., Pyper, W. R., Webb, S. I., Powell, L. W., Morris, C. P., & Walsh, T. P. (1996) · Nature Genetics · doi:10.1038/ng1196-249 · Cited by 419 · see citing works
Jouanolle, A. M., Gandon, G., Jézéquel, P., Blayau, M., Campion, M. L., Yaouanq, J., Mosser, J., Fergelot, P., Chauvel, B., Bouric, P., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-251 · Cited by 340 · see citing works
Body iron stores and risk of cancer
Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliövaara, M., & Hakuunen, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560315 · Cited by 314 · see citing works
Clinical and Biochemical Abnormalities in People Heterozygous for Hemochromatosis
Bulaj, Z. J., Griffen, L. M., Jorde, L. B., Edwards, C. Q., & Kushner, J. P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352403 · Cited by 286 · see citing works
Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis
Fletcher, L. M., Dixon, J. L., Purdie, D. M., Powell, L. W., & Crawford, D. H. (2002) · Gastroenterology · doi:10.1053/gast.2002.30992 · Cited by 285 · see citing works
Fracanzani, A. L. (2001) · Hepatology · doi:10.1053/jhep.2001.22506 · Cited by 246 · see citing works
Long-term survival analysis in hereditary hemochromatosis
Adams, P. C., Speechley, M. R., & Kertesz, A. E. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90013-b · Cited by 242 · see citing works
The person-number systems of Sweden, Norway, Denmark, and Israel.
As, L., Lundeborg, S., Gs, L., Thygesen, L. C., & Huebner, J. (1980) · PubMed · Cited by 206 · see citing works
Surival and Prognostic Factors in 212 Italian Patients With Genetic Hemochromatosis
Fargion, S. R., Mandelli, C., Piperno, A., Cesana, B. M., Fracanzani, A. L., Fraquelli, M., Bianchi, P. A., Fiorelli, G., & Conte, D. (1992) · Hepatology · doi:10.1002/hep.1840150417 · Cited by 199 · see citing works
Bradbear, R. A., Bain, C. J., Siskind, V., Schofield, F. D., Webb, S. I., Axelsen, E., Halliday, J. W., Bassett, M. L., & Powell, L. W. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/75.1.81 · Cited by 195 · see citing works
Crawford, D. H., Jazwinska, E. C., Cullen, L. M., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70320-8 · Cited by 167 · see citing works
Persson, G., Boström, G., Diderichsen, F., Lindberg, G., Pettersson, B., Rosén, M., Stenbeck, M., & Wall, S. (2001) · Scandinavian Journal of Public Health · doi:10.1177/14034948010290032901 · Cited by 148 · see citing works
Yang, Q., McDonnell, S. M., Khoury, M. J., Cono, J., & Parrish, R. G. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00005 · Cited by 147 · see citing works
Cancer risk following primary hemochromatosis: A population‐based cohort study in Denmark
Hsing, A. W., McLaughlin, J. K., Olsen, J. H., Mellemkjar, L., Wacholder, S., & Fraumeni, J. F. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600204 · Cited by 145 · see citing works
Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer
Shaheen, N. J., Silverman, L. M., Keku, T. O., Lawrence, L. B., Rohlfs, E. M., Martin, C. F., Galanko, J., & Sandler, R. S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.154 · Cited by 131 · see citing works
Nelson, R. L., Davis, F. G., Persky, V., & Becker, E. (1995) · Cancer · doi:10.1002/1097-0142(19950901)76:5 · Cited by 126 · see citing works
Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis
Fargion, S. R., Fracanzani, A. L., Piperno, A., Braga, M., D’Alba, R., Ronchi, G., & Fiorelli, G. (1994) · Hepatology · doi:10.1002/hep.1840200608 · Cited by 111 · see citing works
HFE mutations in patients with hereditary haemochromatosis in Sweden
Cardoso, E. M., Stal, P. I., Hagen, Cabeda, Cabeda, Esin, Sousa, D., & Hultcrantz (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00270.x · Cited by 103 · see citing works
Beckman, L. E. (1999) · Carcinogenesis · doi:10.1093/carcin/20.7.1231 · Cited by 100 · see citing works
Hultén, L., Gramatkovski, E., Gleerup, A., & Hallberg, L. (1995) · PubMed · Cited by 95 · see citing works
Brissot, P., Moirand, R., Jouanolle, A., Guyader, D., Gall, J. L., Deugnier, Y., & David, V. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80188-3 · Cited by 87 · see citing works
van Asperen, I. A., Feskens, E. J. M., Bowles, C. H., & Kromhout, D. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.665 · Cited by 70 · see citing works
Deshpande, A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/67.2.275 · Cited by 59 · see citing works
High Incidence of Extrahepatic Carcinomas in Idiopathic Hemochromatosis
Ammann, R., Müller, E., Bansky, J., Schüler, G., & Häcki, W. H. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181523 · Cited by 52 · see citing works
Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
Ryan, E. M., Byrnes, V., Coughlan, B., Flanagan, A.-M., Barrett, S., O’Keane, J. C., & Crowe, S. F. (2002) · Gut · doi:10.1136/gut.51.1.108 · Cited by 47 · see citing works
Höhler, T., Leininger, S., Köhler, H. H., Schirmacher, P., & Galle, P. R. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020006482.x · Cited by 44 · see citing works
Lucotte, G. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0417 · Cited by 37 · see citing works
Macdonald, G. A., Tarish, J., Whitehall, V., Sally, J.-C., Mellick, G. D., Buttenshaw, R. L., Johnson, A. G., Young, J. P., & Leggett, B. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.02027.x · Cited by 36 · see citing works
Tiniakos, G., & Williams, R. C. (1988) · PubMed · Cited by 32 · see citing works
Biochemical expression of heterozygous hereditary hemochromatosis
Valk, B. D., Witlox, R. S. G. M., van der Schouw, Y. T., & Marx, J. J. M. (2000) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(00)00111-4 · Cited by 27 · see citing works
Hereditary hemochromatosis and alcohol: A fibrogenic cocktail
Britton, R. S., & Bacon, B. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.31652 · Cited by 23 · see citing works
Boström, G. (2001) · PubMed · Cited by 6 · see citing works
Chapter 6. Habits of Life and Public Health
Bostrom, G. (2001) · Scandinavian Journal of Public Health · doi:10.1177/14034948010290033601 · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Tiniakos G, Williams R. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Appl Pathol 1988;6:128 -138.
Cited by
Sorted by citations
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,913 · see citing works
Marrero, J. A., Kulik, L., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,549 · see citing works
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,587 · see citing works
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · see citing works
Martin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045 · see citing works
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,023 · see citing works
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., D'Angelica, M. I., Abbott, D. E., Anaya, D. A., Anders, R. A., Are, C., Bachini, M., Borad, M. J., Brown, D. B., Burgoyne, A. M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0022 · Cited by 1,010 · see citing works
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Reghupaty, S. C., Fisher, P. B., & Sarkar, D. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.001 · Cited by 865 · see citing works
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Massarweh, N. N., & El‐Serag, H. B. (2017) · Cancer Control · doi:10.1177/1073274817729245 · Cited by 637 · see citing works
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Toh, M. R., Wong, E. Y. T., Wong, S. H., Ng, A. W. T., Loo, L., Chow, P. K.-H., & Ngeow, J. Y. Y. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.033 · Cited by 600 · see citing works
The Swedish Multi-Generation Register
Ekbom, A. (2011) · Methods in molecular biology · doi:10.1007/978-1-59745-423-0_10 · Cited by 553 · see citing works
Self-citationIntracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526 · see citing works
Hepatocellular carcinoma epidemiology
Bosetti, C., Turati, F., & Vecchia, C. L. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.007 · Cited by 531 · see citing works
Oxidative Stress in Liver Pathophysiology and Disease
Allameh, A., Niayesh‐Mehr, R., Aliarab, A., Sebastiani, G., & Pantopoulos, K. (2023) · Antioxidants · doi:10.3390/antiox12091653 · Cited by 565 · see citing works
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
Tang, A., Hallouch, O., Chernyak, V., Kamaya, A., & Sirlin, C. B. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1209-1 · Cited by 481 · see citing works
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426 · see citing works
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Wang, Y., & Deng, B. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10084-4 · Cited by 434 · see citing works
Ames, B. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608757103 · Cited by 411 · see citing works
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391 · see citing works
The evolving epidemiology of hepatocellular carcinoma: a global perspective
Wallace, M. C., Preen, D. B., Jeffrey, G. P., & Adams, L. A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1028363 · Cited by 374 · see citing works
Iron and Cancer Risk—A Systematic Review and Meta-analysis of the Epidemiological Evidence
Fonseca‐Nunes, A., Jakszyn, P. G., & Agudo, A. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0733 · Cited by 351 · see citing works
Update in global trends and aetiology of hepatocellular carcinoma
Rawla, P., Sunkara, T., Muralidharan, P., & Raj, J. P. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.78941 · Cited by 332 · see citing works
Epidemiology of Hepatocellular Carcinoma
Lafaro, K. J., Demirjian, A. N., & Pawlik, T. M. (2014) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2014.09.001 · Cited by 311 · see citing works
Tumor suppressor p53 and metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy070 · Cited by 298 · see citing works
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 281 · see citing works
ACG Clinical Guideline: Hereditary Hemochromatosis
Kowdley, K. V., Brown, K. E., Ahn, J. C., & Sundaram, V. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000315 · Cited by 281 · see citing works
Targeting iron metabolism in cancer therapy
Morales, M., & Xue, X. (2021) · Theranostics · doi:10.7150/thno.59092 · Cited by 254 · see citing works
Hepatic Iron Overload and Hepatocellular Carcinoma
Kew, M. C. (2014) · Liver Cancer · doi:10.1159/000343856 · Cited by 241 · see citing works
Risk of HCC: Genetic heterogeneity and complex genetics
Dragani, T. A. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.015 · Cited by 226 · see citing works
Hepatocellular carcinoma surveillance: An evidence-based approach
Harris, P. S., Hansen, R. M., Gray, M. E., Massoud, O. I., McGuire, B. M., & Shoreibah, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i13.1550 · Cited by 219 · see citing works
Shen, J., Sheng, X., Chang, Z., Wu, Q., Wang, S., Xuan, Z., Li, D., Wu, Y., Shang, Y., Kong, X., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.042 · Cited by 215 · see citing works
Epidemiology and Management of Hepatocellular Carcinoma
Yang, J. D., & Roberts, L. R. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.004 · Cited by 213 · see citing works
Epidemiology of Primary and Secondary Liver Cancers
Ananthakrishnan, A. N., Gogineni, V., & Saeian, K. (2006) · Seminars in Interventional Radiology · doi:10.1055/s-2006-939841 · Cited by 205 · see citing works
Whitlock, E. P., Garlitz, B. A., Harris, E. L., Beil, T. L., & Smith, P. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-3-200608010-00009 · Cited by 200 · see citing works
Elsayed, M., Sharif, M., & Stack, A. G. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.03.002 · Cited by 180 · see citing works
Non-viral causes of hepatocellular carcinoma
Blonski, W. C. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i29.3603 · Cited by 176 · see citing works
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
Nahon, P., & Zucman‐Rossi, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.035 · Cited by 174 · see citing works
Hepatocellular Cancer: A Guide for the Internist
Parikh, S., & Hyman, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.11.020 · Cited by 169 · see citing works
Review article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162 · see citing works
Torti, S. V., & Torti, F. M. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100860 · Cited by 153 · see citing works
Molecular mechanisms of oxidative stress‐induced carcinogenesis: From epidemiology to oxygenomics
Toyokuni, S. (2008) · IUBMB Life · doi:10.1002/iub.61 · Cited by 151 · see citing works
AASLD PRACTICE GUIDELINE Management of Hepatocellular Carcinoma: An Update
Bruix, J., & Sherman, M. (2010) · Cited by 155 · see citing works
Risk Factors of Hepatocellular Carcinoma - Current Status and Perspectives
Gao, J., Xie, L., Yang, W., Zhang, W., Gao, S., Wang, J., & Xiang, Y. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.743 · Cited by 145 · see citing works
Prevention of hepatocellular carcinoma in the Asia–Pacific region: Consensus statements
Carcinoma, A. W. P. O. P. O. H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06167.x · Cited by 139 · see citing works
Ironing out mechanisms of iron homeostasis and disorders of iron deficiency
Koleini, N., Shapiro, J. S., Geier, J., & Ardehali, H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148671 · Cited by 145 · see citing works
HFE-associated hereditary hemochromatosis
Alexander, J., & Kowdley, K. V. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31819d30f2 · Cited by 132 · see citing works
Kalinowski, D. S., Stefani, C., Toyokuni, S., Ganz, T., Anderson, G. J., Subramaniam, V. N., Trinder, D., Olynyk, J. K., Chua, A. C. G., Jansson, P. J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.026 · Cited by 129 · see citing works
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Swinkels, D. W., Janssen, M. C. H., Bergmans, J., & Marx, J. J. M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068684 · Cited by 116 · see citing works
Iron: An Essential Element of Cancer Metabolism
Hsu, M. Y., Mina, E., Roetto, A., & Porporato, P. E. (2020) · Cells · doi:10.3390/cells9122591 · Cited by 116 · see citing works
Hepatic iron overload and hepatocellular carcinoma
Kew, M. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.001 · Cited by 107 · see citing works
Shiani, A., Narayanan, S., Peña, L., & Friedman, M. (2017) · Cancer Control · doi:10.1177/1073274817729240 · Cited by 103 · see citing works
Olynyk, J. K., Pierre, T. G. S., Britton, R. S., Brunt, E. M., & Bacon, B. R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41287.x · Cited by 98 · see citing works
Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer
Torti, S. V., & Torti, F. M. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007784 · Cited by 93 · see citing works
Ko, C. W., Siddaiah, N. B., Berger, J., Gish, R. G., Brandhagen, D. J., Sterling, R. K., Cotler, S. J., Fontana, R. J., McCashland, T. M., Han, S. H. B., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01596.x · Cited by 93 · see citing works
Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis
Zenouzi, R., Weismüller, T. J., Hübener, P., Schulze, K., Bubenheim, M., Pannicke, N., Weiler–Normann, C., Lenzen, H., Manns, M. P., Lohse, A. W., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.008 · Cited by 86 · see citing works
Lodato, F. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i45.7239 · Cited by 79 · see citing works
Iron: An emerging factor in colorectal carcinogenesis
Chua, A. C. G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i6.663 · Cited by 77 · see citing works
Treating iron overload in patients with non‐transfusion‐dependent thalassemia
Taher, A. T., Viprakasit, V., Musallam, K. M., & Cappellini, M. D. (2013) · American Journal of Hematology · doi:10.1002/ajh.23405 · Cited by 76 · see citing works
Hepatocellular carcinoma in patients with autoimmune hepatitis
Teufel, A., Weinmann, A., Centner, C., Piendl, A., Lohse, A. W., Galle, P. R., & Kanzler, S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.578 · Cited by 72 · see citing works
A Prospective Study of Hepatocellular Carcinoma Incidence in Thalassemia
Mancuso, A., Sciarrino, E., Renda, M. C., & Maggio, A. (2006) · Hemoglobin · doi:10.1080/03630260500455565 · Cited by 71 · see citing works
Nutrients intake and the risk of hepatocellular carcinoma in Italy
Polesel, J., Talamini, R., Montella, M., Maso, L. D., Crovatto, M., Parpinel, M. T., Izzo, F., Tommasi, L. G., Serraino, D., Vecchia, C. L., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.012 · Cited by 70 · see citing works
Development of Hepatocellular Carcinoma in Autoimmune Hepatitis Patients: A Case Series
Wong, R. J., Gish, R. G., Frederick, R. T., Bzowej, N. H., & Frenette, C. T. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1444-6 · Cited by 69 · see citing works
Iron and liver cancer: an inseparable connection
Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 68 · see citing works
Global Gene Expression Profiling Reveals SPINK1 as a Potential Hepatocellular Carcinoma Marker
Marshall, A., Lukk, M., Kutter, C., Davies, S. E., Alexander, G., & Odom, D. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059459 · Cited by 67 · see citing works
Risk factors for developing hepatocellular carcinoma in Egypt.
Omar, A., Abou‐Alfa, G. K., Khairy, A. M., & Omar, H. (2013) · PubMed · doi:10.3978/j.issn.2304-3865.2013.11.07 · Cited by 67 · see citing works
Kobayashi, Y., Ohfuji, S., Kondo, K., Fukushima, W., Sasaki, S., Kamata, N., Yamagami, H., Fujiwara, Y., Suzuki, Y., Hirota, Y., et al. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14642 · Cited by 66 · see citing works
Optimal micronutrients delay mitochondrial decay and age-associated diseases
Ames, B. N. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.04.005 · Cited by 65 · see citing works
Barton, J. C., & Acton, R. T. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9826930 · Cited by 65 · see citing works
Non-viral factors contributing to hepatocellular carcinoma
Hamed, M. A. A., & Ali, S. A. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i6.311 · Cited by 65 · see citing works
Chan, A. T., Ma, J., Tranah, G. J., Giovannucci, E. L., Rifai, N., Hunter, D. J., & Fuchs, C. S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji165 · Cited by 64 · see citing works
Harrison, S. A., & Bacon, B. R. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.08.005 · Cited by 62 · see citing works
Hepatocellular Carcinoma: Epidemiology, Screening, and Assessment of Hepatic Reserve
Frager, S. Z., & Schwartz, J. M. (2020) · Current Oncology · doi:10.3747/co.27.7181 · Cited by 60 · see citing works
Non-B, non-C hepatocellular carcinoma
Nishikawa, H., & Osaki, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2061 · Cited by 59 · see citing works
Revisiting Hereditary Hemochromatosis: Current Concepts and Progress
Yen, A. W., Fancher, T. L., & Bowlus, C. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.041 · Cited by 58 · see citing works
Hepatocellular carcinoma in thalassemia: A critical review
Mancuso, A. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i5.171 · Cited by 57 · see citing works
Indications for liver transplantation in adults
Graziadei, I. W., Zoller, H., Fickert, P., Schneeberger, S., Finkenstedt, A., Peck‐Radosavljevic, M., Müller, H., Kohl, C. A., Sperner‐Unterweger, B., Eschertzhuber, S., et al. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-1046-1 · Cited by 57 · see citing works
Méndez‐Sánchez, N., Ridruejo, E., de Mattos, Â. A., Chávez-Tapia, N. C., Zapata, R., Paraná, R., Mastaï, R., Strauss, E., Guevara-Casallas, L. G., Daruich, J. R., et al. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30919-6 · Cited by 56 · see citing works
Surveillance for Hepatocellular Carcinoma
Corte, C. D., & Colombo, M. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.002 · Cited by 55 · see citing works
Delima, R. D., Chua, A. C. G., Tirnitz‐Parker, J. E. E., Gan, E. K., Croft, K. D., Graham, R. M., Olynyk, J. K., & Trinder, D. (2012) · Hepatology · doi:10.1002/hep.25689 · Cited by 54 · see citing works
Hepatocellular Carcinoma and Other Malignancies in Autoimmune Hepatitis
Czaja, A. J. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2525-5 · Cited by 54 · see citing works
Prevention of mutation, Cancer, and other Age-Associated diseases by optimizing micronutrient intake
Ames, B. N. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/725071 · Cited by 51 · see citing works
Lehmann, U., Wingen, L. U., Brakensiek, K., Wedemeyer, H. H., Becker, T., Heim, A., Metzig, K., Hasemeier, B., Kreipe, H. H., & Flemming, P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm082 · Cited by 51 · see citing works
Yun, S., & Vincelette, N. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.006 · Cited by 51 · see citing works
Shen, L., Saviano, A., Erstad, D. J., Hoshida, Y., Fuchs, B. C., Baumert, T. F., & Tanabe, K. K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123817 · Cited by 49 · see citing works
Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances
Navin, P. J., & Venkatesh, S. K. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00032 · Cited by 48 · see citing works
Liu, Y.-T., Shang, D., Akatsuka, S., Ohara, H., Dutta, K. K., Mizushima, K., Naito, Y., Yoshikawa, T., Izumiya, M., Abe, K., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070741 · Cited by 48 · see citing works
Screening for hepatocellular carcinoma
Sherman, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.11.006 · Cited by 48 · see citing works
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041166 · Cited by 47 · see citing works
Trace Element Concentration in Primary Liver Cancers—A Systematic Review
Gurusamy, K. S. (2007) · Biological Trace Element Research · doi:10.1007/s12011-007-0008-x · Cited by 46 · see citing works
Hemochromatosis gene (HFE) mutations and cancer risk
Fargion, S. R., Valenti, L. V. C., & Fracanzani, A. L. (2010) · Hepatology · doi:10.1002/hep.23541 · Cited by 46 · see citing works
Outcome of liver transplantation in hereditary hemochromatosis
Dar, F. S., Faraj, W. G., Zaman, M. B., Bartlett, A. S., Bomford, A. B., O’Sullivan, A., O’Grady, J., Heneghan, M. A., Rela, M., & Heaton, N. D. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00863.x · Cited by 45 · see citing works
Janssen, M. C. H., & Swinkels, D. W. (2009) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.02.004 · Cited by 46 · see citing works
Elmberg, M., Hultcrantz, R. W., Simard, J. F., Carlsson, Å., & Askling, J. (2012) · Arthritis Care & Research · doi:10.1002/acr.21883 · Cited by 44 · see citing works
Self-citationLi, M., Tang, Y., Wang, D., Zhai, X., Shen, H., Chen, Z., Yao, M., Jin, A., Zhou, Z., Zhou, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.09.012 · Cited by 44 · see citing works
The antioxidant status of the plasma in patients with breast cancer undergoing chemotherapy
Abdel‐Salam, O. M. E., Youness, E. R., & Hafez, H. F. (2011) · Open Journal of Molecular and Integrative Physiology · doi:10.4236/ojmip.2011.13005 · Cited by 43 · see citing works
Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells
Zhang, L., Zhang, J., Jin, Y., Yao, G., Zhao, H., Qiao, P., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728172 · Cited by 42 · see citing works
Hepatocellular Carcinoma in Asia: A Challenging Situation
Jafri, W., & Kamran, M. A. (2019) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1292 · Cited by 43 · see citing works
Calvisi, D. F., Frau, M., Tomasi, M. L., Feo, F., & Pascale, R. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.003 · Cited by 40 · see citing works
Pathological investigation of oxidative stress in the post‐genomic era
Toyokuni, S., & Akatsuka, S. (2007) · Pathology International · doi:10.1111/j.1440-1827.2007.02127.x · Cited by 40 · see citing works
Prevention of hepatocellular carcinoma in nonviral‐related liver diseases
Fan, J., Farrell, G. C., & Carcinoma, T. A. W. P. F. P. O. H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05776.x · Cited by 39 · see citing works
- Authors
- Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., Almer, S., Sandberg-Gertzén, H., & Askling, J.
- Affiliations
- Karolinska University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- Uppsala University Hospital (SE)
- Linköping University Hospital (SE)
- Corresponding author
- Elmberg, Maria
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 125
- Issue
- 6
- Pages
- 1733-1741
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2165680505
- Cited by
- 273
- References
- 41
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 14 · 2023: 9 · 2022: 8 · 2021: 14 · 2020: 14 · 2019: 12 · 2018: 8 · 2017: 11 · 2016: 11 · 2015: 8 · 2014: 15 · 2013: 19 · 2012: 17
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Cancerfonden
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Keywords
- hereditary hemochromatosis, cancer risk, iron overload, hepatocellular carcinoma, liver cancer, gastrointestinal cancer, first-degree relatives, heterozygous carriers, familial cancer risk
- MeSH terms
- Hemochromatosis Protein, Adolescent, Adult, Aged, Aged, 80 and over, Female, Hemochromatosis, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Membrane Proteins, Middle Aged, Mutation, Risk, Histocompatibility Antigens Class I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
